Low-Risk, Aggressive Diffuse Large B-Cell Lymphoma: Rituximab Added to CHOP-Like Chemo Improves Outcome in Younger Patients


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles